Clinical Trials Logo

Clinical Trial Summary

The purpose is to assess visualize the level of laryngeal obstruction and vocal cord dysfunction and to obtain more information on causes for dyspnea in asthma and severe asthma and to assess safety of CLE in patients with asthma and with severe asthma. Patients are examined if symptomatic during exercise.


Clinical Trial Description

- Questionnaires to assess breathlessness before the test. - CLE on ergometer bicycle using any laryngoscopy setup - Ergometry with spirometry tests with ECG, oxygen saturation, blood pressure, inspiratory and expiratory flow volume curves, bronchodilator after the exercise test - Work load of 40W with 3 minutes intervals and increase by 40W in women. In men, work load of 50W with 3 minutes intervals and increase by 50W starting from 50W. In elderly and more severely disease work load of 30W with 3 minutes intervals and increase by 30W. - Recording of dyspnoea, leg fatigue and chest discomfort - Assessment of asthma by asthma control test, spirometry, exhaled NO measurements. - Severe asthma group: physician-diagnosed asthma, moderate-high dose inhaled glucorticoid steroids and a second controller drug, exacerbations and per oral glucocorticoid steroid courses at least 2 in the past 12 months and/or 50% of the past 12 months on per oral glucocorticoidsteroids ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04168671
Study type Interventional
Source Helsinki University Central Hospital
Contact
Status Withdrawn
Phase N/A
Start date March 1, 2019
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT05746780 - Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Active, not recruiting NCT03529422 - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Phase 2
Completed NCT02126969 - A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Phase 2
Completed NCT01263873 - Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube N/A
Completed NCT03162731 - Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer Early Phase 1
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Completed NCT01649973 - Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy N/A
Completed NCT01321892 - Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium N/A
Recruiting NCT05636410 - Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
Recruiting NCT05565430 - Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
Completed NCT03109873 - Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer Early Phase 1
Active, not recruiting NCT03737968 - Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. Phase 2
Recruiting NCT03109171 - Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea N/A
Completed NCT02761239 - Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve N/A
Recruiting NCT05145556 - Teach Intubation by Novices in Anaesthesiology N/A
Completed NCT03030781 - Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging. N/A
Completed NCT03238365 - Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Early Phase 1
Withdrawn NCT02065128 - The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome N/A
Active, not recruiting NCT03854032 - Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Phase 2
Active, not recruiting NCT03076281 - Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Phase 2